Health Committee Chair Alexander Questions Merit Of Drug Rebates

Senate health committee Chair Lamar Alexander (R-TN) questioned the merit of drug rebates at a hearing Tuesday (Oct. 17) on drug prices. The hearing also included tough questions to other sectors of the drug supply chain, including the distributors that previously were all but absent in the debate over prices. “Why do we need rebates at all?” Alexander asked. “Wouldn’t it increase transparency if the drug manufacturers just established a list price and then they negotiated with the pharmacy benefit...